89bio Inc
ETNB
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.2B
Close$
$0.85
94.3% downside
Current Fair Value
94.3% downsideOvervalued by 94.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.20 Billion |
|---|---|
| Enterprise Value | $2.07 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.51 |
| Beta | 1.26 |
| Outstanding Shares | 157,880,203 |
Return
| Return on Equity | -86.29% |
|---|---|
| Return on Assets | -74.60% |
| Return on Invested Capital | -81.06% |
Valuation & Multiples
| P/E Ratio | -7.78 |
|---|---|
| PEG | -5.87 |
| Price to Sales | - |
| Price to Book Ratio | 4.95 |
| Enterprise Value to Revenue | 98721.26 |
| Enterprise Value to EBIT | -4.54 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 6, 2025
EPS Estimate
$-0.50
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 8.3776▲ 298.88% |
|---|---|
| Total Calls | 773,900▲ 158.48% |
| Total Puts | 6,483,397▲ 301.85% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 97.98%▼ 4.12% |
|---|---|
| Total Invested | $2.27B▲ 43.61% |
| Investors Holding | 227▲ 25.00% |
ESG Score
No data